Infertility, miscarriage, ectopic pregnancy

PubMed Free Full Text

Assisted reproductive technology: ovarian stimulation, hormone therapy

Australia

• SA Health
  • Ovarian Hyperstimulation Syndrome

Belgium, France

• Frontiers in Reproductive Health
  • From patient classification to optimized treatment in ART: the AMPLITUDE Delphi consensus [2024]

Canada

• Society of Obstetricians and Gynaecologists of Canada
  • Prevention of Ovarian Hyperstimulation Syndrome [2023]

China

• Clinical and Public Health Guidelines
  • Recommendations for the management of GnRH-ant for ovarian stimulation in the assistant reproductive process: Benefits and harms for different ovarian response population [2025]

Denmark

• Danish Medical Journal
  • Annual incidence of severe ovarian hyperstimulation syndrome [2021]

Europe

• European Society of Human Reproduction and Embryology
  • ESHRE guideline: ovarian stimulation for IVF/ICSI [2020]

France

• Best Practice & Research Clinical Endocrinology & Metabolism
  • Comparative effectiveness of gonadotropins used for ovarian stimulation during assisted reproductive technologies (ART) in France: A real-world observational study from the French nationwide claims database (SNDS) [2023]

Germany

• Best Practice & Research Clinical Obstetrics & Gynaecology
  • Effectiveness of recombinant human follicle-stimulating hormone (r-hFSH): recombinant human luteinizing hormone versus r-hFSH alone in assisted reproductive technology treatment cycles among women aged 35-40 years: A German database study [2023]

India

• Journal of Human Reproductive Sciences
  • Ovarian Stimulation in Assisted Reproductive Technology Cycles for Varied Patient Profiles: An Indian Perspective [2022]

International

• BJOG: An International Journal of Obstetrics & Gynaecology
  • Comparison of Luteal Support Protocols in Frozen IVF/ICSI Cycles: A Network Meta-Analysis [2025]

• Cochrane Database of Systematic Reviews
  • Growth hormone for in vitro fertilisation (IVF) [2021]
  • Dopamine agonists for preventing ovarian hyperstimulation syndrome [2021]

• Frontiers in Endocrinology
  • Optimising Follicular Development, Pituitary Suppression, Triggering and Luteal Phase Support During Assisted Reproductive Technology: A Delphi Consensus [2021]
  • Improving Reporting of Clinical Studies Using the POSEIDON Criteria: POSORT Guidelines [2021]
  • Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria—The Why [2018]

• Human Reproduction Update
  • Development and validation of a gonadotropin dose selection model for optimized ovarian stimulation in IVF/ICSI: an individual participant data meta-analysis [2025]

• International Journal of Molecular Sciences
  • Novel Physiology and Definition of Poor Ovarian Response; Clinical Recommendations [2020]

• International Society for Mild Approaches in Assisted Reproduction
  • The case for mild stimulation for IVF: recommendations from The International Society for Mild Approaches in Assisted Reproduction [2022]

• Journal of Assisted Reproduction and Genetics
  • How effective are the non-conventional ovarian stimulation protocols in ART? A systematic review and meta-analysis [2020]

• Journal of Medical Internet Research
  • Harnessing Artificial Intelligence to Predict Ovarian Stimulation Outcomes in In Vitro Fertilization: Scoping Review [2024]

• Reproductive Biology and Endocrinology
  • Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as part of medically-assisted reproduction in clinical studies: a systematic review covering 10 years (2007–2017) [2021]
  • A 10-year follow-up on the practice of luteal phase support using worldwide web-based surveys [2021]

• Reproductive BioMedicine Online
  • Management of ovarian stimulation for IVF: narrative review of evidence provided for World Health Organization guidance [2017]

• Scientific Reports
  • Comparison of luteal support protocols in fresh IVF/ICSI cycles: a network meta-analysis [2024]

Italy

• European Review for Medical and Pharmacological Sciences
  • GnRH antagonists in assisted reproductive techniques: a review on the Italian experience [2013]

• Human Reproduction
  • A retrospective evaluation of prognosis and cost-effectiveness of IVF in poor responders according to the Bologna criteria [2015]

Middle East

• Frontiers in Endocrinology
  • FSH/LH co-stimulation in Advanced Maternal Age (AMA) and hypo-responder patients - Arabian gulf delphi consensus group [2024]

Spain

• Journal of Obstetrics and Gynaecology
  • Use of gonadotropins in ovarian stimulation in Spain: Delphi consensus [2023]

Sweden

• ClinicoEconomics and Outcomes Research
  • Economic evaluation of highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone in fresh and frozen in vitro fertilization/intracytoplasmic sperm-injection cycles in Sweden [2013]

United Kingdom

• British Fertility Society
  • Prevention of ovarian hyperstimulation syndrome (OHSS): British Fertility Society policy and practice guideline [2025]
  • Venous thromboembolism associated with medically assisted reproduction (MAR): British fertility society policy and practice guidance for assessment and prevention [2024]

United States

• American Society for Reproductive Medicine
  • Prevention of moderate and severe ovarian hyperstimulation syndrome: a guideline [2024]
  • Comparison of pregnancy rates for poor responders using IVF with mild ovarian stimulation versus conventional IVF: a guideline [2018]

• Fertility and Sterility
  • Ovarian hyperstimulation syndrome after assisted reproductive technologies: trends, predictors, and pregnancy outcomes [2020]

• Society for Assisted Reproductive Technology
  • Total follicle stimulating hormone dose is negatively correlated with live births in a donor/recipient model with fresh transfer: an analysis of 8,627 cycles from the Society for Assisted Reproductive Technology Registry [2020]
  • Differential impact of controlled ovarian hyperstimulation on live birth rate in fresh versus frozen embryo transfer cycles: a Society for Assisted Reproductive Technology Clinic Outcome System study [2020]

• Women's Health Reports
  • Minimal Stimulation Using Gonadotropin-Releasing Hormone Antagonist is Associated with Higher Live Birth Rates: A National Study of 13,050 Cycles [2022]

{Related topics}

• Topic
  • Female infertility treatment
  • Assisted reproductive technology